Prof. Dr. LEVENT KABASAKAL

Yayın Ağı

Makaleler 108

1. Prognostic implications of [¹⁸F]FDG PET and metabolic changes in patients with advanced metastatic neuroendocrine tumors undergoing rechallenge PRRT: final results from a multicenter 10-year survival WARMTH study

Santo G., Rodrigues M., Paez D., Morozova O., KABASAKAL L., Kairemo K., et al.

THERANOSTICS , cilt.16, sa.3, ss.1227-1237, 2026 (SCI-Expanded, Scopus)

2. Investigating Combination Therapy: The Role of Lutetium-177 PSMA-617 Radioligand Therapy and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer

Kinikoglu O., Oven B. B., Celik S., ALAN SELÇUK N., Beydagi G., Akcay K., et al.

JOURNAL OF CLINICAL MEDICINE , cilt.13, sa.16, 2024 (SCI-Expanded, Scopus)

3. Revision of the Histopathological Examination Following 68Ga- DOTA-FAPI-04 PET/CT of a Breast Tumor Diagnosed as Invasive Ductal Carcinomatosis

ALAN SELÇUK N., Akcay K., Beydagi G., Sonmez O., Celik S., Oven B. B., et al.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , sa.2, ss.134-137, 2024 (ESCI, TRDizin)

4. Value of Ga-68 PSMA PET/CT in ISUP Grade 2 Prostate Cancer Patients

Aghazada F., Demirbilek M., Sahin O., Asa S., Onal B., KABASAKAL L.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , sa.SUPPL 1, 2023 (SCI-Expanded, Scopus)

5. The role of PSMA PET/CT in the diagnosis of clinically significant prostate cancer

Kibar A., Sahin O. E., Asa S., Demirbilek M., Bilgic S., Onal B., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , sa.SUPPL 1, 2023 (SCI-Expanded, Scopus)

6. Psma PET/CT Results and Effect on Treatment in Patients with Biochemical Recurrence After Radical Prostatectomy

Akcay K., Selcuk N., Beydagi G., Toklu T., Demirci E., Sonmez O., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , sa.SUPPL 1, 2023 (SCI-Expanded, Scopus)

7. THE RELATIONSHIP BETWEEN TUMOR MEAN STANDARD UPTAKE VALUE (SUVMAX) IN PREOPERATIVE PET/COMPUTED TOMOGRAPHY AND PROGNOSTIC RISK GROUPS IN ENDOMETRIAL CANCER

Bese T. T., Bicer E., Kosuk A. T., Akovali B., Turan H., Kabasakal L., et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , 2023 (SCI-Expanded, Scopus)

8. Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)

Kratochwil C., Fendler W. P., Eiber M., Hofman M. S., Emmett L., Calais J., et al.

European Journal of Nuclear Medicine and Molecular Imaging , cilt.50, sa.9, ss.2830-2845, 2023 (SCI-Expanded, Scopus)

9. Differentiated Thyroid Cancer in Children and Adolescents: Clinicopathological Characteristics of 32 Patients Followed up in our Pediatric Endocrinology Unit

Çakır A. D., Bucak F. T., Tarçın G., Turan H., Özcan R., Evliyaoğlu O., et al.

Şişli Etfal Hastanesi Tıp Bülteni , cilt.57, sa.2, ss.224-231, 2023 (ESCI, TRDizin)

10. Original research patients undergoing multiple F-18-FDG PET/CT scans: frequency, clinical indications, and cumulative dose

ABUQBEITAH M., DEMİR M., Soenmezoglu K., SAYMAN H. B., KABASAKAL L., Sager S., et al.

HEALTH AND TECHNOLOGY , cilt.13, sa.1, ss.89-97, 2023 (ESCI, Scopus)

11. Contribution of PSMA PET/CT to Evaluation of Response to Systemic Therapies: Preliminary Results

Beydagi G., Demirci E., Selcuk N. A., Akcay K., Ocak M., Toklu T., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus)

12. Peptide-Receptor Radionuclide Therapy (PRRT) with 225Ac-DOTA-TATE: Initial Results and Contribution to Progression-Free Survival

Beydagi G., Demirci E., Selcuk N. A., Ocak M., Toklu T., Akcay K., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus)

13. Value of Personalized Radiation Absorbed Dose Calculation for Radioiodine Ablation Therapy

Sahin O., Selcuk N. A., Yeyin N., Akyel R., Toklu T., Beytur M. F., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus)

14. The Role of [Ga-68]Ga-DOTA-FAPI-04 PET/CT on Altering Stage in Patients with Non-FDG-avid Lesions

Beydagi G., Selcuk N. A., Demirci E., Akcay K., Oven B., Celik S., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus)

15. Almost Complete Response with a Single Administration Ac-225-DOTATATE in a Patient with a Metastatic Neuroendocrine Tumor of Unknown Primary

ALAN SELÇUK N., Demirci E., Ocak M., Toklu T., Ergen S., KABASAKAL L.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.31, sa.2, ss.139-141, 2022 (ESCI, Scopus, TRDizin)

16. Ga-[68]DOTA-FAPI-04 PET/CT imaging in a case of a signet ring cell carcinoma of stomach

ALAN SELÇUK N., Ergen S., Demirci E., Ocak M., KABASAKAL L.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.48, sa.13, ss.4523-4524, 2021 (SCI-Expanded, Scopus)

17. Evaluation of F-18 DOPA PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: comparison with GA-68 DOTA-TATE PET/CT

Asa S., Sönmezoğlu K., Uslu-Besli L., Şahin O. E., Karayel E., Pehlivanoglu H., et al.

ANNALS OF NUCLEAR MEDICINE , cilt.35, ss.900-915, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

18. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms

Ambrosini V., Kunikowska J., Baudin E., Bodei L., Bouvier C., Capdevila J., et al.

EUROPEAN JOURNAL OF CANCER , cilt.146, ss.56-73, 2021 (SCI-Expanded, Scopus)

19. Therapy-related chronic myeloid leukemia in a patient receiving peptide receptor radionuclide therapy for pancreatic neuroendocrine tumor

Kucukyurt S., Yagiz Ozogul Y., Ercaliskan A., Kabasakal L., Eskazan A. E.

CANCER REPORTS , cilt.3, sa.5, 2020 (ESCI, Scopus)

20. Post-therapy imaging of Ac-225-DOTATATE treatment in a patient with recurrent neuroendocrine tumor

Ocak M., Toklu T., Demirci E., ALAN SELÇUK N., Kabasakal L.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.47, sa.11, ss.2711-2712, 2020 (SCI-Expanded, Scopus)

21. Interobserver and intraobserver agreement on prostate-specific membrane antigen PET/CT images according to the miTNM and PSMA-RADS criteria

Demirci E., Akyel R., Caner B., ALAN SELÇUK N., Guven-Mese S., Ocak M., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.41, sa.8, ss.759-767, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

22. Performance of F-18 Fluorocholine PET/CT for Detection of Hyperfunctioning Parathyroid Tissue in Patients with Elevated Parathyroid Hormone Levels and Negative or Discrepant Results in Conventional Imaging

Uslu-Beşli L., Sonmezoglu K., Teksoz S., Akgun E., Karayel E., Pehlivanoglu H., et al.

KOREAN JOURNAL OF RADIOLOGY , cilt.21, sa.2, ss.236-247, 2020 (SCI-Expanded, Scopus)

23. EANM procedure guidelines for radionuclide therapy with Lu-177-labelled PSMA-ligands (Lu-177-PSMA-RLT)

Kratochwil C., Fendler W. P., Eiber M., Baum R., BOZKURT M. F., Czernin J., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.46, sa.12, ss.2536-2544, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

24. Prognostic value of ADC measurements in predicting overall survival in patients undergoing Y-90 radioembolization for colorectal cancer liver metastases

Alis D., Durmaz E. S. M., GÜLŞEN F., BAŞ A., KABASAKAL L., Sager S., et al.

CLINICAL IMAGING , cilt.57, ss.124-130, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

25. Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer?

Demirci E., Kabasakal L., Sahin O. E., Akgun E., Gultekin M. H., Doganca T., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.40, sa.1, ss.86-91, 2019 (SCI-Expanded, Scopus)

26. ESTIMATION OF THE ORGAN ABSORBED DOSES AND EFFECTIVE DOSE FROM Ga-68-PSMA-11 PET SCAN

Demirci E., Toklu T., Yeyin N., Ocak M., ALAN SELÇUK N., Araman A., et al.

RADIATION PROTECTION DOSIMETRY , cilt.182, sa.4, ss.518-524, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. Indirect assessment of the maximum empirical activity (250 mCi) with respect to dosimetry concepts in radioiodine therapy of metastatic differentiated thyroid cancer

Abuqbeitah M., Demir M., Kabasakal L., Cavdar I., Uslu-Besli L., Yeyin N., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.39, sa.11, ss.969-975, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

28. Red bone marrow dose estimation using several internal dosimetry models for prospective dosimetry-oriented radioiodine therapy

Abuqbeitah M., Demir M., Cavdar I., Tanyildizi H., Yeyin N., Uslu-Besli L., et al.

RADIATION AND ENVIRONMENTAL BIOPHYSICS , cilt.57, sa.4, ss.395-404, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

29. Lu-177-DOTATATE therapy in patients with neuroendocrine tumours including high-grade (WHO G3) neuroendocrine tumours: response to treatment and long-term survival update

Demirci E., Kabasakal L., Toklu T., Ocak M., Sahin O. E., ALAN SELÇUK N., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.39, sa.8, ss.789-796, 2018 (SCI-Expanded, Scopus)

30. Abdominal Splenosis Mimicking Peritoneal Metastasis in Prostate-Specific Membrane Antigen PET/CT, Confirmed With Selective Spleen SPECT/CT

Demirci E., Simsek D. H., Kabasakal L., Mulazimoglu M.

CLINICAL NUCLEAR MEDICINE , cilt.42, sa.12, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

31. Orbital flourine-18-fluorodeoxyglucose positron emission tomography in patients with Graves' disease for evaluation of active inflammation

Uslu-Besli L., Kabasakal L., Sager S., Cicik E., Asa S., Sonmezoglu K.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.38, sa.11, ss.964-970, 2017 (SCI-Expanded, Scopus)

32. 177Lu-PSMA-617 Treatment of Metastatic Castration-Resistant Prostate Cancer: Efficacy and Survival

Demirci E., Akyel R., Sahin O. E., Ocak M., Aygun A., Pehlivanoglu H., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , 2017 (SCI-Expanded, Scopus)

33. Comparison of F-18 Choline PET/CT with Tc-99m MIBI and USG for Detection of Parathyroid Adenomas in Patients with Elevated Parathyroid Hormone Levels: Preliminary Results

Uslu-Beli L., Sonmezoglu K., Akgun E. K., Teksoz S., Karayel E., Pehlivanoglu H., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , 2017 (SCI-Expanded, Scopus)

34. The accuracy of Ga-68-PSMA PET/CT in primary lymph node staging in high-risk prostate cancer

Obek C., DOGANCA T., Demirci E., Ocak M., Kural A. R., YILDIRIM A., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.44, sa.11, ss.1806-1812, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

35. Lu-177-PSMA-617 Prostate-Specific Membrane Antigen Inhibitor Therapy in Patients with Castration-Resistant Prostate Cancer: Stability, Bio-distribution and Dosimetry

Kabasakal L., Toklu T., Yeyin N., Demirci E., Abuqbeitah M., Ocak M., et al.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.26, sa.2, ss.62-68, 2017 (ESCI, Scopus, TRDizin)

36. The role of PSMA PET/CT imaging in restaging of prostate cancer patients with low prostate-specific antigen levels

Kabasakal L., Demirci E., Nematyazar J., Akyel R., Razavi B., Ocak M., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.38, sa.2, ss.149-155, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

37. Information about Prostate Cancer for Urologist: Ga-68 Prostate Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Scintigraphy

Kabasakal L.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.15, sa.4, ss.159-162, 2016 (ESCI, TRDizin) Sürdürülebilir Kalkınma

38. Normal distribution pattern and physiological variants of Ga-68-PSMA-11 PET/CT imaging

Demirci E., Sahin O. E., Ocak M., Akovali B., Nematyazar J., Kabasakal L.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.37, sa.11, ss.1169-1179, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

39. Long-Term Palliative Effect of Stenting in Gastric Outlet Obstruction Due to Transarterial Chemoembolization with Yttrium-90 in a Patient with Metastatic Neuroendocrine Tumor.

CAGLAR E., DOĞUSOY G., KABASAKAL L., Dobrucali A. M.

Clinical endoscopy , cilt.49, ss.479-482, 2016 (ESCI, Scopus)

40. Evaluation of radiation safety in Lu-177-PSMA therapy and development of outpatient treatment protocol

DEMIR M., ABUQBEITAH M., Uslu-Beşli L., YıLDıRıM Ö., YEYIN N., CAVDAR I., et al.

JOURNAL OF RADIOLOGICAL PROTECTION , cilt.36, sa.2, ss.269-278, 2016 (SCI-Expanded, Scopus)

41. Normal Distribution Pattern and Physiological Variants of Ga-68-PSMA PET/CT

Demirci E., Sahin O. E., Ocak M., Akovali B., Kabasakal L.

JOURNAL OF NUCLEAR MEDICINE , cilt.57, 2016 (SCI-Expanded, Scopus)

42. Breast Uptake of Ga-68 DOTA-TATE in a Nursing Woman with Net Diagnosis

Aksoy S. Y., Vatankulu B., Akgun E., Halac M., Kabasakal L., Sonmezoglu K.

GAZI MEDICAL JOURNAL , cilt.27, sa.3, ss.176-177, 2016 (ESCI, Scopus, TRDizin)

43. Pre-therapeutic dosimetry of normal organs and tissues of Lu-177-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer

Kabasakal L., AbuQbeitah M., Aygun A., Yeyin N., Ocak M., Demirci E., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.42, sa.13, ss.1976-1983, 2015 (SCI-Expanded, Scopus)

44. Evaluation of Liver Stiffness After Radioembolization by Real-Time ShearWave (TM) Elastography: Preliminary Study

Bas A., Samanci C., Gulsen F., Cantasdemir M., Kabasakal L., Kantarci F., et al.

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY , cilt.38, sa.4, ss.957-963, 2015 (SCI-Expanded, Scopus)

45. Evaluation of PSMA PET/CT imaging using a Ga-68-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging

Kabasakal L., Demirci E., Ocak M., Akyel R., Nematyazar J., Aygun A., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.36, sa.6, ss.582-587, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

46. Ga-68-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma

Demirci E., Ocak M., Kabasakal L., Decristoforo C., Talat Z., Halac M., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.41, sa.7, ss.1461-1462, 2014 (SCI-Expanded, Scopus)

47. FDG and FDG-labelled leucocyte PET/CT in the imaging of prosthetic joint infection

Aksoy S. Y., Asa S., Ozhan M., Ocak M., Sager M. S., Erkan M. E., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.41, sa.3, ss.556-564, 2014 (SCI-Expanded, Scopus)

48. Clinical value of technetium-99m-labeled octreotide scintigraphy in local recurrent or metastatic medullary thyroid cancers: a comparison of lesions with F-18-FDG-PET and MIBI images

Sager S., Kabasakal L., Ocak M., Maecke H., Uslu L., Halac M., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.34, sa.12, ss.1190-1195, 2013 (SCI-Expanded, Scopus)

49. Evaluation and comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-NOC PET/CT imaging in well-differentiated thyroid cancer

Ocak M., Demirci E., Kabasakal L., Aygun A., Tutar R. O., Araman A., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.34, ss.1084-1089, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

50. Imaging of multiple brown tumors both in FDG (F-18) and Ga-68 DOTA-TATE PET/CT studies

Asa S., Yilmaz S., Kaya R., Sager S., Halac M., Kabasakal L.

REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR , cilt.32, sa.6, ss.404-405, 2013 (SCI-Expanded, Scopus)

51. Comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-LAN PET/CT imaging in the same patient group with neuroendocrine tumours: preliminary results

Demirci E., Ocak M., Kabasakal L., Araman A., Ozsoy Y., Kanmaz B.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.34, sa.8, ss.727-732, 2013 (SCI-Expanded, Scopus)

52. Comparison of Tc-99m-HYNIC-TOC and HYNIC-TATE Octreotide Scintigraphy With FDG PET and Tc-99m-MIBI in Local Recurrent or Distant Metastatic Thyroid Cancers

Sager S., Kabasakal L., Halac M., Maecke H., Uslu L., Onsel C., et al.

CLINICAL NUCLEAR MEDICINE , cilt.38, sa.5, ss.321-325, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

53. Von Hippel Lindau disease with metastatic pancreatic neuroendocrine tumor causing ectopic Cushing's syndrome

Hatipoglu E., Kepicoglu H., Rusen E., Kabasakal L., Gundogdu S., Kadioglu P.

NEUROENDOCRINOLOGY LETTERS , cilt.34, sa.1, ss.9-13, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

54. Appearance of intracranial meningioma in FDG and 68Ga-DOTATOC PET/CT.

YILMAZ S., Ocak M., Asa S., Gülsen F., HALAC M., Kabasakal L.

Revista espanola de medicina nuclear e imagen molecular , cilt.32, ss.60-1, 2013 (SCI-Expanded, Scopus)

55. The different distribution patterns of FDG and FDG-labelled WBC in inflammatory and infectious lesions

Yilmaz S., Ocak M., Asa S., Aliyev A., Ozhan M., Halac M., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.39, sa.10, ss.1660-1661, 2012 (SCI-Expanded, Scopus)

56. Comparison of Ga-68-DOTATATE and Ga-68-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours

Kabasakal L., Demirci E., Ocak M., Decristoforo C., Araman A., Ozsoy Y., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.39, sa.8, ss.1271-1277, 2012 (SCI-Expanded, Scopus)

57. Comparison of positron emission tomography with 68Ga-DOTA-TATE and 18F FDG in neuroendocrine tumours

Yilmaz S., Demirci E., Ocak M., Aygun A., Halac M., Sager S., et al.

JOURNAL OF NUCLEAR MEDICINE , cilt.53, 2012 (SCI-Expanded, Scopus)

58. Increased orbital rectus muscle F-18 FDG uptake and its correlation with muscle thickness in Graves' patients

Uslu L., Kabasakal L., Cicik E., Halac M., Kanmaz B.

JOURNAL OF NUCLEAR MEDICINE , cilt.53, 2012 (SCI-Expanded, Scopus)

59. 177Lu-[DOTA0, Tyr3] octreotate therapy in iodine refractory thyroid cancer: Comparison of dosimetry with therapy of thyroid cancer and neuroendocrine tumors

Yeyin N., Toklu T., Demirci E., Kabasakal L., Aygun A., Ocak M., et al.

JOURNAL OF NUCLEAR MEDICINE , cilt.53, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

60. Evaluation of 68Ga-DOTA-TATE and 68Ga-DOTA-NOC PET/CT in patients with differentiated thyroid cancer

Demirci E., Kabasakal L., Ocak M., Aygun A., Halac M., Kanmaz B.

JOURNAL OF NUCLEAR MEDICINE , cilt.53, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

61. Comparison of I-123 MIBG scintigraphy with somatostatin receptor scintigraphy using Tc-99m HYNIC TATE in neuroblastoma patients

Uslu L., Kabasakal L., Ocak M., Tuysuz G., Celkan T., Apak H., et al.

JOURNAL OF NUCLEAR MEDICINE , cilt.53, 2012 (SCI-Expanded, Scopus)

62. Intraoperative Localization of Recurrent Medullary Carcinoma of the Thyroid Using Tc-99m HYNIC-TATE and a Surgical Gamma Probe

Aliyev A., Ocak M., Kabasakal L., Haciyev Y., Ozhan M., Vural O., et al.

CLINICAL NUCLEAR MEDICINE , cilt.36, sa.9, ss.831-833, 2011 (SCI-Expanded, Scopus)

63. Influence of biological assay conditions on stability assessment of radiometal-labelled peptides exemplified using a Lu-177-DOTA-minigastrin derivative

Ocak M., Helbok A., von Guggenberg E., Ozsoy Y., Kabasakal L., Kremser L., et al.

NUCLEAR MEDICINE AND BIOLOGY , cilt.38, sa.2, ss.171-179, 2011 (SCI-Expanded, Scopus)

64. Temporal relationship between gastroesophageal reflux and rate of gastric emptying in children

Sager S., Halac M., Selcuk N., Dogan I., Kabasakal L., Onsel C., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.31, sa.12, ss.1059-1062, 2010 (SCI-Expanded, Scopus)

65. Intravascular radiation therapy with a Re-188 liquid-filled balloon in patients with in-stent restenosis

Selcuk N. A., Onsel C., OZTURK S., Gurmen T., Gulbaran M., Sager S., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.31, sa.8, ss.746-752, 2010 (SCI-Expanded, Scopus)

66. The value of different washout parameters in the evaluation of renal transplants by technetium-99m-ethylene-I-I-dicysteine

Kanmaz B., Sayman H. B., ALAN SELÇUK N., Devranoglu G., Nisli S., Sonmezoglu K., et al.

HELLENIC JOURNAL OF NUCLEAR MEDICINE , cilt.13, sa.2, ss.127-131, 2010 (SCI-Expanded, Scopus)

67. Ectopic Parathyroid Adenoma Localized With MIBI Scintigraphy and Excised With Guide of Macroaggregated Human Serum Albumin Injection

Aliyev A., Kabasakal L., Simsek O., Paksoy M., Halac M., Uslu I.

CLINICAL NUCLEAR MEDICINE , cilt.35, sa.3, ss.151-153, 2010 (SCI-Expanded, Scopus)

68. The effect of prepubertal ovariohysterectomy on spine 1 mineral density and mineral content in puppies: A preliminary study

Ekici H., Sontas B. H., Toydemir T. S. F., Şenmevsim Ö., Kabasakal L., İmre Y.

RESEARCH IN VETERINARY SCIENCE , cilt.82, sa.1, ss.105-109, 2007 (SCI-Expanded, Scopus)

69. Propylthiouracil-induced hypothyroidism protects ionizing radiation-induced multiple organ damage in rats

Sener G., Kabasakal L., ATASOY B. M., ERZİK C., Velioglu-Ogunc A., Cetinel S., et al.

JOURNAL OF ENDOCRINOLOGY , cilt.189, sa.2, ss.257-269, 2006 (SCI-Expanded, Scopus)

70. Is the I-131 whole-body scanning proper for follow-up management of patients with malignant struma ovarii without performing thyroidectomy?

Balci T., Kabasakal L.

GYNECOLOGIC ONCOLOGY , cilt.99, sa.2, ss.520, 2005 (SCI-Expanded, Scopus)

71. A dynamic renal phantom for nuclear medicine studies

Ahmed A., Demir M., Kabasakal l., Uslu H.

MEDICAL PHYSICS , cilt.32, sa.2, ss.530-538, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

72. Treatment of iodine-negative thyroglobulin-positive thyroid cancer: differences in outcome in patients with macrometastases and patients with micrometastases

Kabasakal L., Selcuk N., Shafipour H., Ozmen O., Onsel C., Uslu I.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.31, sa.11, ss.1500-1504, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

73. Treatment of iodine negative, thyroglobulin positive, thyroid cancer patients: Do we miss the target when we shoot in the dark?

Kabasakal L.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.24, sa.7, ss.739-741, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

74. Guidelines for radioiodinated MIBG scintigraphy in children

Olivier P., Colarinha P., Fettich J., Fischer S., Frokier J., Giammarile F., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.30, sa.5, 2003 (SCI-Expanded, Scopus)

75. Guidelines for direct radionuclide cystography in children

Fettich J., Colarinha P., Fischer S., Frokier J., Gordon I., Hahn K., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.30, sa.5, 2003 (SCI-Expanded, Scopus)

76. The effects of exposure of Co-60 on the oxidant/antioxidant status among radiation victims

Demir M., Konukoglu D., Kabasakal L., Yelke H., Ergen K., Ahmed S.

JOURNAL OF ENVIRONMENTAL RADIOACTIVITY , cilt.64, sa.1, ss.19-25, 2003 (SCI-Expanded, Scopus)

77. Is furosemide administration effective in improving the accuracy of determination of differential renal function by means of technetium-99m DMSA in patients with hydronephrosis

Kabasakal L., Turkmen C., Ozmen O., Alan N., Onsel C., Uslu I.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.29, sa.11, ss.1433-1437, 2002 (SCI-Expanded, Scopus)

78. Diagnostic value of Tc-99m-methylene diphosphonate and Tc-99m-pentavalent DMSA compared with Tc-99m-sestamibi for palpable breast lesions

Massardo T., Alonso O., Kabasakal L., Llamas-Olier A., Shankar U., Zhu H., et al.

JOURNAL OF NUCLEAR MEDICINE , cilt.43, sa.7, ss.882-888, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

79. Is Tc-99m-sestamibi scintimammography complementary to conventional mammography for detecting breast cancer in patients with palpable masses?

Alonso O., Massardo T., Delgado L., Horvath J., Kabasakal L., Llamas-Olier A., et al.

JOURNAL OF NUCLEAR MEDICINE , cilt.42, sa.11, ss.1614-1621, 2001 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

80. Guidelines for standard and diuretic renography in children

Gordon I., Colarinha P., Fettich J., Fischer S., Frokier J., Hahn K., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE , cilt.28, sa.3, 2001 (SCI-Expanded, Scopus)

81. Guidelines for indirect radionuclide cystography

Gordon I., Colarinha P., Fettich J., Fischer S., Frokier J., Hahn K., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE , cilt.28, sa.3, 2001 (SCI-Expanded, Scopus)

82. Comparison of Tc-99m-methoxyisobutyl isonitrile and Tl-201 scintigraphy in visualization of suppressed thyroid tissue

Erdil T., Onsel C., Kanmaz B., Caner B., Sonmezoglu K., Ciftci I., et al.

JOURNAL OF NUCLEAR MEDICINE , cilt.41, sa.7, ss.1163-1167, 2000 (SCI-Expanded, Scopus)

83. Correlation of technetium-99m MIBI and thallium-201 retention in solitary cold thyroid nodules with postoperative histopathology

Erdil T., Ozker K., Kabasakal L., Kanmaz B., Sonmezoglu K., Atasoy K., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE , cilt.27, sa.6, ss.713-720, 2000 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

84. Ictal and interictal SPECT findings in childhood absence epilepsy

Yeni S., Kabasakal L., Yalcinkaya C., Nisli C., Dervent A.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY , cilt.9, sa.4, ss.265-269, 2000 (SCI-Expanded, Scopus)

85. The role of Tc-99(m)-tetrofosmin in the evaluation of thyroid nodules

Kanmaz B., Erdil T., Yardi O., SAYMAN H. B., Kabasakal L., SÖNMEZOĞLU K., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.21, sa.4, ss.333-339, 2000 (SCI-Expanded, Scopus)

86. Technetium-99m ethylene dicysteine: a new renal tubular function agent

Kabasakal L.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE , cilt.27, sa.3, ss.351-357, 2000 (SCI-Expanded, Scopus)

87. The effect of P-glycoprotein function inhibition with cyclosporine A on the biodistribution of Tc-99m sestamibi

Kabasakal L., Halac M., Nisli C., Oguz O., Onsel C., Civi G., et al.

CLINICAL NUCLEAR MEDICINE , cilt.25, sa.1, ss.20-23, 2000 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

88. Biodistribution of Tc-99(m)-labelled 5-thio-D-glucose

Ozker K., Collier B., Lindner D., Kabasakal L., Liu Y., Krasnow A., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.20, sa.11, ss.1055-1058, 1999 (SCI-Expanded, Scopus)

89. The results and statistical analysis of distant metastases from differentiated thyroid cancer

Kanmaz B., Firuzi F., Onsel C., Gonca , SÖNMEZOĞLU K., KABASAKAL L., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE , cilt.26, sa.9, ss.1091, 1999 (SCI-Expanded) Sürdürülebilir Kalkınma

90. The effect of radioiodine treatment on plasma peroxides and vitamin E level in thyroidectomized patients. T

KONUKOĞLU D., DEMİR M., KEMERLİ DEMİRİZ G., KABASAKAL L., HATEMİ H.

Turkısh J Nuclear Medicine , cilt.8, ss.103-109, 1999 (Hakemli Dergi)

91. Reproducibility of technetium-99m ethylenedicysteine clearance

Kabasakal L., Halac M., Alkan E., Ozcelik N., Uslu I.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE , cilt.26, sa.8, ss.900-902, 1999 (SCI-Expanded, Scopus)

92. Prospective validation of single plasma sample Tc-99m-ethylenedicysteine clearance in adults

Kabasakal L., Halac M., Yapar A., Alkan E., Kanmaz B., Onsel C., et al.

JOURNAL OF NUCLEAR MEDICINE , cilt.40, sa.3, ss.429-431, 1999 (SCI-Expanded, Scopus)

93. Evaluation of renal function in low-dose cyclosporine-treated patients using technetium-99m diaminocyclohexane: a cationic tubular excretion agent

Sönmezoğlu K., Erdil T., Demir M., Sayman H. B., Kabasakal L., Yardı Ö., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE , cilt.25, sa.12, ss.1630-1636, 1998 (SCI-Expanded, Scopus)

94. HİPERBARİK OKSİJEN UYGULAMASININ FARELERDE OTOKLAVİZE OTOJEN KEMİK GREFTİNİN İNKORPORASYONU ÜZERİNE ETKİSİ (DENEYSEL ÇALIŞMA)

ERDOĞAN F., Orak M., AKTAŞ Ş., TÜRECİ E., OLGAÇ N. V., KABASAKAL L., et al.

ACTA ORTHOPAEDICA ET TRAUMATOLOGICA TURCICA , cilt.32, ss.226-231, 1998 (SCI-Expanded, Scopus, TRDizin)

95. Simplified technetium-99m-EC clearance in adults from a single plasma sample

Kabasakal L., Yapar A., Ozker K., Alkan E., Atay S., Ozcelik N., et al.

JOURNAL OF NUCLEAR MEDICINE , cilt.38, sa.11, ss.1784-1786, 1997 (SCI-Expanded, Scopus)

96. Evaluation of Tc-99(m)-bicisate as a renal imaging agent

Ozker K., Kabasakal L., Liu Y., Hellman R., Isitman A., Krasnow A., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.18, sa.8, ss.771-775, 1997 (SCI-Expanded, Scopus)

97. EKSTREMITE AMELİYATLARINDA TURNİKE AÇMA ZAMANININ POSTOPERATİF HEMATOM OLUŞUMUNA ETKİSİ (DENEYSEL ÇALIŞMA)

AYDINGÖZ Ö., ERDOĞAN F., Kabasakal L., Karadeniz N., Ök M., Yentür E., et al.

ACTA ORTHOPAEDICA ET TRAUMATOLOGICA TURCICA , cilt.31, sa.3, ss.255-261, 1997 (SCI-Expanded, Scopus, TRDizin)

98. Simplified determination of technetium-99m ethylenedicysteine clearance from a single plasma sample: What is the upper normal range?

Kabasakal L., Onsel C.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE , cilt.23, sa.11, ss.1556, 1996 (SCI-Expanded, Scopus)

99. Hipertriodili Hastalarda Tedavi Öncesi ve Sonrası Çinko Düzeyi Ölçümleri

DEMİR M., GÜNEBAKAN S., Mete C., Yapar A., KABASAKAL L., Yurttaş B., et al.

ENDOKRİNOLOJİDE YÖNELİŞLER , cilt.5, sa.3, ss.85-87, 1996 (Hakemli Dergi)

100. Evaluation of external radiation exposure rate from radioiodine-treated hyperthyroid patients and radiation safety considerations

Demir M., Kabasakal L., Onsel C.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.17, sa.8, ss.692-695, 1996 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

101. Enterogastric bile reflux during technetium-99m-sestamibi cardiac imaging

Kabasakal L., Collier B., Shaker R., Hellman R., Smart S., Ozker K., et al.

JOURNAL OF NUCLEAR MEDICINE , cilt.37, sa.8, ss.1285-1288, 1996 (SCI-Expanded, Scopus)

102. Technetium-99m sestamibi uptake in human breast carcinoma cell lines displaying glutathione-associated drug-resistance

Kabasakal L., Ozker K., Hayward M., Akansel G., Griffith O., Isitman A., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE , cilt.23, sa.5, ss.568-570, 1996 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

103. Hipertiroidili hastalarda tedavi öncesi ve sonrası çinko düzeyi ölçümleri.

DEMİR M., Günebakan S., Mete C., Yapar A. F., Kabasakal L., Soytürk B., et al.

Endokrinolojide Yönelişler Dergisi , cilt.5, ss.85-87, 1996 (Hakemli Dergi)

104. EVALUATION OF TECHNETIUM-99M-ETHYLENEDICYSTEINE IN RENAL DISORDERS AND DETERMINATION OF EXTRACTION RATIO

KABASAKAL L., ATAY S., VURAL V., OZKER K., SONMEZOGLU K., DEMIR M., et al.

JOURNAL OF NUCLEAR MEDICINE , cilt.36, sa.8, ss.1398-1403, 1995 (SCI-Expanded, Scopus)

105. BRAIN SPECT EVALUATION OF THE VISUAL-CORTEX IN AMBLYOPIA

KABASAKAL L., DEVRANOGLU K., ARSLAN O. Ş., ERDIL T., SONMEZOGLU K., USLU I., et al.

JOURNAL OF NUCLEAR MEDICINE , cilt.36, sa.7, ss.1170-1174, 1995 (SCI-Expanded, Scopus)

106. CLINICAL COMPARISON OF TECHNETIUM-99M-EC, TECHNETIUM-99M-MAG3 AND IODINE-131-OIH IN RENAL DISORDERS

KABASAKAL L., TUROGLU H., ONSEL C., OZKER K., USLU I., ATAY S., et al.

JOURNAL OF NUCLEAR MEDICINE , cilt.36, sa.2, ss.224-228, 1995 (SCI-Expanded, Scopus)

107. RELATIONSHIP BETWEEN THE OIH AND TC-99(M)-EC CLEARANCES

KABASAKAL L., OZKER K., ISITMAN A., ONSEL C.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.15, sa.12, ss.1006-1007, 1994 (SCI-Expanded, Scopus)

108. TECHNETIUM-99M-N,N-ETHYLENEDICYSTEINE - A COMPARATIVE-STUDY OF RENAL SCINTIGRAPHY WITH TECHNETIUM-99M-MAG3 AND IODINE-131-OIH IN PATIENTS WITH OBSTRUCTIVE RENAL-DISEASE

OZKER K., ONSEL C., KABASAKAL L., SAYMAN H. B., USLU I., BOZLUOLCAY S., et al.

JOURNAL OF NUCLEAR MEDICINE , cilt.35, sa.5, ss.840-845, 1994 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 14

1. Evaluation of Tc-99m-EC in renal disorders

DEMİR M., Kabasakal L.

European Nuclear Medicine Congress 1994, Almanya, (Özet Bildiri)

2. Selective Internal Radiation Therapy (SIRT) for Liver Metastasis of Chemoresistant Breast Cancer: Overall Survival and Dose - Response Relationship

Akovali B., Akgun E. K., Şahin O. A., Yeyin N., Abuqbeitah M., Tanyildizi H., et al.

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri) Sürdürülebilir Kalkınma

3. Determination of Radiation Dose in 177Lu-DOTATATE Treatment with 99m-Tc-HYNICTATE Scintigraphy

Yeyin N., Toklu T., Aygun A., Karayel E., Pehlivanoglu H., Demirci E., et al.

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, (Özet Bildiri)

4. Retrospective visualization of the cystic artery on hepatic angiographic images: Is there any risk for radiation-induced cholecystitis after radioembolization with Y-90 microspheres?

Selcuk N. A., Topcuoglu M., Toklu T., Demirci E., Sarsilmaz A., Kabasakal L.

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri)

5. Can SUVmax Values of 68Ga-PSMA PET/CT scan Predict the Clinically Significant Prostate Cancer

Sahin O. E., Akgun E., Demirci E., Gultekin M., Doganca T., Tuna M., et al.

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri) Sürdürülebilir Kalkınma

6. Desing of Experimental Liver Phantom with Multifocal Tumor Implication for Use in Yttrium 90 Radioembolization Dosimetry

Tanyildizi H., Karadeniz A., DEMİR M., Kabasakal L.

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri)

7. Comparison of F18 DOPA and Ga68 DOTA TATE in detection of recurrences or metastasis of medullary thyroid cancer

ASA S., SÖNMEZOĞLU K., AKGÜN E., RAZAVIKHOSROSHAHI S., TEKSÖZ S., OCAK DEMİRCİ E. M., et al.

European Association of Nuclear Medicine Congress 2017, Viyana, Avustralya, 21 - 25 Ekim 2017, ss.1, (Özet Bildiri) Sürdürülebilir Kalkınma

8. THE ACCURACY OF 68GALLIUM-PSMA PET/CT IN PRIMARY LYMPH NODE STAGING FOR HIGH RISK PROSTATE CANCER

Obek C., DOGANCA T., Demirci E., Ocak M., Kural A. R., YILDIRIM A., et al.

Annual Meeting of the American-Urological-Association (AUA), Massachusetts, Amerika Birleşik Devletleri, 12 - 16 Mayıs 2017, cilt.197, (Özet Bildiri) Sürdürülebilir Kalkınma